Bypassing Peer Review

Your data's solid. Your results are impressive. Your methodology's near foolproof. It's time to submit your research for publication. So, of course, you place a call to--the New York Times? The practice isn't new: For a variety of reasons, companies sometimes choose to pitch their research results straight to the popular press--or, in recent years, to anyone who happens upon their Web press release--rather than first submitting their findings to a peer-reviewed journal. Sometimes they don't even

Written byEugene Russo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Your data's solid. Your results are impressive. Your methodology's near foolproof. It's time to submit your research for publication. So, of course, you place a call to--the New York Times? The practice isn't new: For a variety of reasons, companies sometimes choose to pitch their research results straight to the popular press--or, in recent years, to anyone who happens upon their Web press release--rather than first submitting their findings to a peer-reviewed journal. Sometimes they don't even announce the findings at a meeting first. National Human Genome Research Institute (NHGRI) director Francis Collins calls the practice "regrettable," but regrettably not new. He does suggest that the release of findings without disclosing hard data is "picking up in genetics and genomics" because those findings are "perceived as having more business value than they used to."

Donald Kennedy is wary of any system that steps around peer review. According to the incoming ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems